A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle. This fireside chat was recorded during the Lytham Partners Fall 2025 Investor Conference.
Reviva (Nasdaq: RVPH) is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens to society, patients, and their families. This fireside chat was...
Cadrenal Therapeutics, Inc. is a biopharmaceutical company developing transformative therapeutics to address limitations of current anticoagulation therapy. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.
INVO Fertility (Nasdaq: IVF) is a healthcare services fertility company dedicated to expanding assisted reproductive technology (“ART”) care to patients in need. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.
Modular Medical (Nasdaq: MODD) is a development-stage, medical device company focused on the design, development, and commercialization of an innovative insulin pump using modernized technology to increase pump adoption in the diabetes marketplace. This fireside chat...
Sonoma Pharmaceuticals is a global healthcare leader for developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and...
Dyadic Applied BioSolutions (Nasdaq: DYAI) is a global biotechnology company that uses its proprietary microbial platforms to produce recombinant proteins that are sold or licensed to partners across the life sciences, food and nutrition, and bio-industrial markets....
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid...
Nutex Health Inc. (Nasdaq: NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.
Alpha Tau (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into solid tumors. This company webcast was recorded during the Lytham Partners Fall 2025 Investor Conference.